The plasma industry has huge 10 billion dollar companies like Grifols. The red blood cell industry is mostly dominated by the Red Cross in most places, but also includes smaller non profits and some for-profit companies. The margins for red blood cells sold to hospitals are really thin (they charge ~$200 per unit, depending on a lot of factors), and I don’t think those companies are as sketchy and profit driven as the plasma industry.
I would still recommend donating blood. Hospitals really need that stuff, and it gets expensive when it hard to find donors.
Most blood banks (including the Red Cross) won’t accept hemochromatomates as donors, so all that perfectly good blood gets poured down the drain. The ostensible reason is they don’t want “motivated donors”, the real reason is because blood banks get fat reimbursements for “therapeutic phlebotomies”.
It looks like FDA changed the regulations in 2016 to allow blood centers to accept donations from patients with hereditary hemochromatosis. I wonder what fraction of blood centers in the US actually accept such donations, though. (Sadly, it doesn't surprise me that reimbursements would be a driving factor for throwing away perfectly usable blood.)
Is there a reason why the government/insurance don't change their policies? It seems pretty weird for all parties involved to throw away blood from "therapeutic phlebotomies".
Of course you market to people likely to respond. I doubt you’d get hedge fund chairmen or senators to respond.
capitalism does not mean evil business. these are not investments